Group-based Integrative Pain Management: A multi-level approach to address intersectional stigma and social isolation in diverse primary care safety net patients with chronic pain
Project Number4R33MD018333-02
Former Number4R61MD018333-02
Contact PI/Project LeaderCHAO, MARIA T
Awardee OrganizationUNIVERSITY OF CALIFORNIA, SAN FRANCISCO
Description
Abstract Text
PROJECT ABSTRACT
Background: The proposed study seeks to address chronic pain disparities in racially diverse,
socioeconomically disadvantaged individuals by optimizing multimodal pain management provided in primary
care safety net clinics. Multilevel barriers exist in primary care settings where socioeconomically disadvantaged
patients are most often treated. Lack of access to multimodal and nonpharmacologic care at the organizational
level, and provider bias and other forms of discrimination at the interpersonal level contribute to unequal
assessment, treatment, and quality of pain care. Stigmatization cross-cuts all levels and is closely linked with
social isolation common among individuals with chronic pain. Group-based models are a promising multilevel
approach to increase access to non-pharmacologic therapies, address time constraints that contribute to
disparities in pain care, improve interpersonal communication, and provide social support among safety net
patients with chronic pain. Methods: This study uses mixed methods and a pragmatic 2x2 randomized
factorial trial to test two group-based models: integrative group medical visits (IGMV) and group acupuncture.
The study tests the hypotheses that compared with usual care, each study intervention improves pain
interference and social isolation (primary outcomes), and that the two combined have synergistic effects
mediated by increased social support and decreased impact of intersectional stigma among safety net patients
with chronic pain. Study interventions include 12 weekly sessions based on existing protocols tested in primary
care safety net settings. IGMV includes pain education, social and behavioral support, and mind-body
approaches (meditation, yoga). Group acupuncture uses responsive manualization, allowing for a standardized
yet individualized treatment. During the R61 phase, a panel of national experts and patient stakeholders will
refine and optimize the structure, process, and content of IGMV aimed at reducing social isolation and
intersectional stigma as part of pain management. Interventions will be piloted in 40 English or Spanish
speaking patients with chronic pain at two primary care safety net clinics. Study procedures will be tested and
adapted for a larger scale trial. In the R33 phase, 360 participants will be recruited from two safety net clinics
and randomized to IGMV, group acupuncture, both, or neither. Aim 1 is to determine the effects of study
interventions on pain-related outcomes (primary outcomes: pain interference and social isolation). Aim 2 tests
social support and stigma as intervention mediators. Aim 3 examines patient experiences with pain
management, patient-clinician relationships, and clinical care in primary care safety net settings using
qualitative methods. Significance: Multilevel approaches are need to advance health equity in pain
management. The proposed study will contribute to knowledge of group-based integrative pain management
co-located in primary care to address disparities in pain care for socioeconomically vulnerable populations.
Public Health Relevance Statement
PROJECT NARRATIVE
Socioeconomically disadvantaged populations have a high prevalence of chronic pain, exacerbated by social
isolation, intersectional stigma, and disparities in pain assessment and treatment options. Effective
interventions using a multilevel, biopsychosocial approach are needed to decrease the unequal burden of pain.
The proposed study will test group-based integrative models of pain management in primary care safety net
clinics to improve pain care for racially and ethnically diverse low-income patients.
National Institute on Minority Health and Health Disparities
CFDA Code
307
DUNS Number
094878337
UEI
KMH5K9V7S518
Project Start Date
12-August-2022
Project End Date
30-April-2027
Budget Start Date
01-May-2024
Budget End Date
30-April-2027
Project Funding Information for 2024
Total Funding
$3,752,243
Direct Costs
$2,323,370
Indirect Costs
$1,428,873
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Neurological Disorders and Stroke
$3,752,243
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 4R33MD018333-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 4R33MD018333-02
Patents
No Patents information available for 4R33MD018333-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 4R33MD018333-02
Clinical Studies
No Clinical Studies information available for 4R33MD018333-02
News and More
Related News Releases
No news release information available for 4R33MD018333-02
History
No Historical information available for 4R33MD018333-02
Similar Projects
No Similar Projects information available for 4R33MD018333-02